VXRT — Vaxart Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Vaxart, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13.5	127	166	95.7	39.7
Net Total Accounts Receivable
Net Total Receivables	3.62	0.334	0.071	0.02	3.01
Prepaid Expenses
Total Current Assets	17.6	129	169	99.5	45.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.2	8.32	19.8	41.3	36.6
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	37	153	221	154	91.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.17	11.8	10.8	17.9	13.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	24.1	29.2	33.6	43.3	34
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	13	123	188	111	57.8
Total Liabilities & Shareholders' Equity	37	153	221	154	91.8
Total Common Shares Outstanding